Shanghai, China

Zheng Xia



Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Innovations of Zheng Xia in Neurodegenerative Disorder Treatment

Introduction

Zheng Xia is a notable inventor based in Shanghai, China. He has made significant contributions to the pharmaceutical field, particularly in the treatment of neurodegenerative disorders. His innovative work focuses on developing novel compounds that can potentially improve the lives of those affected by conditions such as Alzheimer's Disease.

Latest Patents

Zheng Xia holds a patent for "Bivalent (−)-meptazinol compounds and/or their salts, and their preparation and utilization." This invention relates to a new family of bivalent (−)-meptazinol compounds, which have shown promise in treating neurodegenerative disorders. The compounds were synthesized from (−)-meptazinol through a series of chemical processes, including N-demethylation and acylation or alkylation. The results from in vitro tests indicate that these compounds are effective inhibitors of both AChE and Aβ aggregation, with the most potent compound demonstrating remarkable efficacy.

Career Highlights

Throughout his career, Zheng Xia has worked with various institutions, including Fudan University. His research has focused on synthesizing compounds that can inhibit cholinesterase and reduce Aβ aggregation, which are critical factors in the progression of Alzheimer's Disease. His innovative approach has led to the development of compounds that are significantly more potent than existing treatments.

Collaborations

Zheng Xia has collaborated with notable colleagues such as Zhuibai Qiu and Qiong Xie. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Zheng Xia's contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative disorders, highlight his innovative spirit and dedication to improving healthcare. His work on bivalent (−)-meptazinol compounds represents a significant advancement in the search for effective treatments for Alzheimer's Disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…